Pharmafile Logo

Full Panel Discussion: Closing The Gaps In Patient-Centricity

October 21, 2022 | Medscape, medical education, oncology 

On 11th September, the Medscape team came together at the Eiffel Tower for an exciting event attended by expert faculty, patient advocates and more than a hundred supporters of our oncology education programmes. The discussion panel consisted of world-renowned experts, including WebMD CMO John Whyte MD, Nadia Harbeck, MD, PhD, Lesley Fallowfield, DBE, BSc, DPhil, FMedSci and Steve Clarke, patient advocate and campaigns ambassador, Cancer Research UK, volunteer patient voice, Bowel Cancer UK, and founder of Strive for Five. The discussions focused on the perceived gaps in patient centricity from physician and patient perspectives and considered what improvements are needed to further advance oncology outcomes.Steve Dunn, Oncology Team Lead and Executive Director commented, “Our event at the Eiffel Tower has provoked much interest in the need for focused education that provides the right skills for physicians and the care team to effectively communicate and collaborate with their patients to help them make the best decisions about their future care together. The Medscape platform can provide the necessary reach and expertise to fulfill this unmet need and advance oncology outcomes through evidence-based patient-centric education. There are exciting times ahead.”This Video is of the full panel discussion .If you’re interested in discussing oncology education, please reach out to Stephen Dunn:email: sdunn@webmd.netmobile: +44 7903042284


This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

Medscape Launches “Where Public Health Meets Practice” Learning Center to Translate Public Health Strategies into Patient Care

  The Medscape Division of Public Health announced the launch of the "Where Public Health Meets Practice" Learning Center, a dedicated educational destination on Medscape.org. The new center serves as...

Data, Evidence, Education: Tackling the Global Multi‑Trillion‑Dollar Rare Disease Burden

Rare diseases are individually uncommon, yet together they affect an estimated 300 million+ people worldwide and touch the lives of over one billion when families and caregivers are included. For...

#ShortenTheJourney

For the millions of people living with a rare disease, the path to a diagnosis (if ever received) is often a long and frustrating odyssey. This delay is frequently driven...

Why We Must Stop Normalizing the “Pregnancy Itch”

In the world of rare diseases, success is often measured by the speed of diagnosis. However, for women facing rare liver conditions like Intrahepatic Cholestasis of Pregnancy (ICP), the medical...

The Greatest Form of Caring: Medscape’s Commitment to Advancing Cardiovascular Health

A February Focus on the Heart  While February is known as the month of love, it is also National Heart Month, a time for highlighting the importance of cardiovascular health....

AI, Agility, and Connected Impact at Alliance 2026

Join the Medscape team in Atlanta, February 16–19, 2026, as Alliance celebrates 50 years of excellence in continuing education for health professionals. We’re bringing our 3 decades of experience in...

Why Sleep Health is the Missing Link in Women’s Wellness

While obstructive sleep apnea (OSA) affects approximately 32% of US adults—nearly 80 million people—it remains an "epidemic hiding in plain sight". Perhaps most staggering is that 90% of women with...

The Heart and Mouth Connection Every Woman Needs to Know

For decades, modern medicine has treated the mouth and the body as separate entities. But for Dr. Nieca Goldberg, a renowned cardiologist, and Dr. Maria Ryan, Chief Clinical Officer at...

Uncovering Inequities in Alzheimer’s Disease Screening and Care

  On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, and treatment. Experts from Komodo Health and Medscape shared findings from their...

Where Are We Today With Artificial Intelligence (AI) in Rare Disease Diagnosis and Care?

Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.